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Endothelin-1 (ET-1) is implicated in cardiovascular risk factors such
as obesity, and the endothelin system is prominent in the kidney. In
murine arteries, the contractile proﬁle of the peptide is heterogeneous
among different preparations, and the renal vascular bed is largely
unexplored. Segmental renal arteries branching from the main renal
arteries of age-matched lean and 30 week diet-induced obeseWTmice
were investigated by isometric tension recording in Halpern–Mulvany
myographs. Contractions after administration of big endothelin-1 (bET-
1) or ET-1 (both 10 pM to 100 nM)were determined in the absence and
presence of l-NAME, followed by full concentration–response curves to
serotonin (5-HT) or the TP receptor agonist U46619. At the highest
concentrations of bET-1 contractions were similar in rings of lean
and obese mice in the absence of l-NAME. Inhibition of NO synthesis
facilitated responses particularly in obese animals (n= 6–9, P b 0.01).
Exogenous ET-1 contracted potently preparations of all groups starting
from 3 nM on; the response to the peptide was augmented by obesity
in the absence and presence of l-NAME (each n= 6–10, P b 0.001).
ECE-activity calculated as the ratio of the responses bET/ET-1 was
signiﬁcantly higher in rings from obese mice in the presence of NO at
10 nM (n= 5–9, P b 0.01) and at 30 nM of the peptides in the presence
of l-NAME (n= 6–9, P b 0.05). Contractions to 5-HT and U46619 were
comparable between groups. These experiments demonstrate the high
responsiveness of the renal vascular bed to both endogenous and
exogenous ET-1, and an increased activity of the endothelin system in
obesity, whereas responses to 5-HT2 and TP receptor activation are
unaltered.
doi:10.1016/j.lfs.2013.12.070
ET-1-induced contraction of renal afferent arterioles of Dahl
salt-sensitive rats is impaired by targeted modiﬁcation of a p66
Shc regulatory phosphorylation site
Andrey Sorokina, Bradley Millera, Aron M. Geurtsb, John D. Imigc
aDepartment ofMedicine,Medical College ofWisconsin,Milwaukee,WI, USA
bDepartment of Physiology, Medical College of Wisconsin, Milwaukee,
WI, USA
cDepartment of Pharmacology, Medical College of Wisconsin, Milwaukee,
WI, USA
E-mail address: sorokin@mcw.edu (A. Sorokin)
The adaptor protein p66 Shc, a longevity-associated product of the
Shc1 gene, is implicated in the pathogenesis of age-related diseases
and regulation of sensitivity to oxidative stress. The ability of p66 Shc
to promote age-related diseases requires phosphorylation of serine
36 residue (Ser36). We have shown that endothelin-1 (ET-1), an
important regulator of the renal microcirculation, induces p66 Shc
Ser36 phosphorylation and mediates protein–protein interactions of
p66 Shc in renal cells. As the knownp66 Shc-mediated effects are highly
dependent on Ser36 phosphorylation, we speciﬁcally modiﬁed this
amino acid by introducing a knock-in substitution of this amino acid in
Dahl salt-sensitive (SS) rats. Cell embryos were extracted from SS rats
and mRNA encoding two engineered ZFNs targeting portion of Shc1
gene encoding p66 Shc isoform were injected into the embryo along
with a plasmid template encoding an Ala36 modiﬁcation. The double
strand break caused by microinjection of ZFNs targeting Shc1 gene
stimulated homologous recombination with co-injected template
plasmid containing the desired mutation. We have established a
breeding colony of rats with the Ser36 to Ala36 (S36A) substitution.
The absence of Ser36 phosphorylation in response to ET-1 was con-
ﬁrmed by Western blotting with phosphospeciﬁc antibodies. The
juxtamedullary vasculature was isolated for study from genetically
modiﬁed SS rats and an afferent arteriole was monitored continuously
by videomicroscopy. After control diameter measurements, responses
to ET-1 (0.001–10 nmol/L) were determined in afferent arterioles.
Since preglomerular arterioles isolated from S36A rats exhibit an im-
paired vascular response to ET-1 when compared with their wild type
littermates, p66 Shc is important for ET-1-induced vascular responses in
renal vessels.
doi:10.1016/j.lfs.2013.12.071
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In multiple drug resistance (MDR) cellular transport mechanism,
such as the MDR-1 and the MRP1-5 proteins, is induced. Cells become
resistant by accelerating the efﬂux of reagents being reabsorbed. This
mechanism could be a major component of therapeutic resistance after
proximal tubule activation in chronic proteinuric disease. By qRT-PCR,
we identiﬁed endothelin-1 (ET-1)-inducible MDR-transport proteins
in normal (RPTEC) and tumorous (CAKI-1) proximal tubule cells.
Verapamil and elacridar, a ﬁrst and third generation MDR-inhibitor,
blocked those transport proteins demonstrated by calcein-AM-assay.
Fluorinated calcium was retained best in the cells after elacridar treat-
ment of prestimulated proximal tubule cells and shows a functional
impact. To further analyse the effect of therapy after blocking MDR we
used a previously (von Brandenstein et al., 2010) described regulatory
loop, causally connecting the upregulation of microRNA15a with the
downregulation of PKC alpha after ET-1-stimulation in proximal tubule
cells. Selegilin, an inducer of PKC alpha, downregulates micoRNA15a
levels in ET1-stimulated proximal tubule cells. The therapeutic dose
of selegilin could be signiﬁcantly reduced after pre-treatment with
elacridar. We conclude that: i) blocking the MDR-transport system
in proximal renal tubules overcomes chemoresistance after ET-1-
stimulation; and ii) therapeutic doses of PKC alpha-inducer selegilin
counteracting microRNA15a production can be reduced. This approach
is a ﬁrst step towards an effective therapeutic protection of proximal
tubules being activated by the endothelin system contributing to pro-
teinuria in chronic renal disease.
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